Literature DB >> 31576755

Conformational Flexibility of the Protein-Protein Interfaces of the Ebola Virus VP40 Structural Matrix Filament.

Elumalai Pavadai, Nisha Bhattarai, Prabin Baral, Robert V Stahelin1, Prem P Chapagain, Bernard S Gerstman.   

Abstract

The Ebola virus (EBOV) is a virulent pathogen that causes severe hemorrhagic fever with a high fatality rate in humans. The EBOV transformer protein VP40 plays crucial roles in viral assembly and budding at the plasma membrane of infected cells. One of VP40's roles is to form the long, flexible, pleomorphic filamentous structural matrix for the virus. Each filament contains three unique interfaces: monomer NTD-NTD to form a dimer, dimer-to-dimer NTD-NTD oligomerization to form a hexamer, and end-to-end hexamer CTD-CTD to build the filament. However, the atomic-level details of conformational flexibility of the VP40 filament are still elusive. In this study, we have performed explicit-solvent, all-atom molecular dynamic simulations to explore the conformational flexibility of the three different interface structures of the filament. Using dynamic network analysis and other calculational methods, we find that the CTD-CTD hexamer interface with weak interdomain amino acid communities is the most flexible, and the NTD-NTD oligomer interface with strong interdomain communities is the least flexible. Our study suggests that the high flexibility of the CTD-CTD interface may be essential for the supple bending of the Ebola filovirus, and such flexibility may present a target for molecular interventions to disrupt the Ebola virus functioning.

Entities:  

Year:  2019        PMID: 31576755      PMCID: PMC6995685          DOI: 10.1021/acs.jpcb.9b04674

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  40 in total

1.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Community structure in social and biological networks.

Authors:  M Girvan; M E J Newman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

3.  The Role of the Interdomain Interactions on RfaH Dynamics and Conformational Transformation.

Authors:  Jeevan B GC; Bernard S Gerstman; Prem P Chapagain
Journal:  J Phys Chem B       Date:  2015-09-28       Impact factor: 2.991

Review 4.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

5.  NetworkView: 3D display and analysis of protein·RNA interaction networks.

Authors:  John Eargle; Zaida Luthey-Schulten
Journal:  Bioinformatics       Date:  2012-09-14       Impact factor: 6.937

6.  Insight into binding mechanisms of inhibitors MKP56, MKP73, MKP86, and MKP97 to HIV-1 protease by using molecular dynamics simulation.

Authors:  Shuhua Shi; Shaolong Zhang; Qinggang Zhang
Journal:  J Biomol Struct Dyn       Date:  2017-03-29

7.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

8.  Protein dynamic communities from elastic network models align closely to the communities defined by molecular dynamics.

Authors:  Sambit Kumar Mishra; Robert L Jernigan
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

9.  The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties.

Authors:  F Xavier Gomis-Rüth; Andréa Dessen; Joanna Timmins; Andreas Bracher; Larissa Kolesnikowa; Stephan Becker; Hans Dieter Klenk; Winfried Weissenhorn
Journal:  Structure       Date:  2003-04       Impact factor: 5.006

10.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

Authors:  Bruce Aylward; Philippe Barboza; Luke Bawo; Eric Bertherat; Pepe Bilivogui; Isobel Blake; Rick Brennan; Sylvie Briand; Jethro Magwati Chakauya; Kennedy Chitala; Roland M Conteh; Anne Cori; Alice Croisier; Jean-Marie Dangou; Boubacar Diallo; Christl A Donnelly; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Caroline Fuhrer; Keiji Fukuda; Tini Garske; Alex Gasasira; Stephen Gbanyan; Peter Graaff; Emmanuel Heleze; Amara Jambai; Thibaut Jombart; Francis Kasolo; Albert Mbule Kadiobo; Sakoba Keita; Daniel Kertesz; Moussa Koné; Chris Lane; Jered Markoff; Moses Massaquoi; Harriet Mills; John Mike Mulba; Emmanuel Musa; Joel Myhre; Abdusalam Nasidi; Eric Nilles; Pierre Nouvellet; Deo Nshimirimana; Isabelle Nuttall; Tolbert Nyenswah; Olushayo Olu; Scott Pendergast; William Perea; Jonathan Polonsky; Steven Riley; Olivier Ronveaux; Keita Sakoba; Ravi Santhana Gopala Krishnan; Mikiko Senga; Faisal Shuaib; Maria D Van Kerkhove; Rui Vaz; Niluka Wijekoon Kannangarage; Zabulon Yoti
Journal:  N Engl J Med       Date:  2014-09-22       Impact factor: 91.245

View more
  5 in total

1.  Ebola virus protein VP40 binding to Sec24c for transport to the plasma membrane.

Authors:  Nisha Bhattarai; Elumalai Pavadai; Rudramani Pokhrel; Prabin Baral; Md Lokman Hossen; Robert V Stahelin; Prem P Chapagain; Bernard S Gerstman
Journal:  Proteins       Date:  2021-09-03

2.  A Conserved Tryptophan in the Ebola Virus Matrix Protein C-Terminal Domain Is Required for Efficient Virus-Like Particle Formation.

Authors:  Kristen A Johnson; Rudramani Pokhrel; Melissa R Budicini; Bernard S Gerstman; Prem P Chapagain; Robert V Stahelin
Journal:  Pathogens       Date:  2020-05-22

3.  Protein Folding Interdiction Strategy for Therapeutic Drug Development in Viral Diseases: Ebola VP40 and Influenza A M1.

Authors:  Fernando Bergasa-Caceres; Herschel A Rabitz
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

4.  Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form.

Authors:  Sara Landeras-Bueno; Hal Wasserman; Glenn Oliveira; Zachary L VanAernum; Florian Busch; Zhe Li Salie; Vicki H Wysocki; Kristian Andersen; Erica Ollmann Saphire
Journal:  Cell Rep       Date:  2021-04-13       Impact factor: 9.423

Review 5.  Modeling the Dynamics of Protein-Protein Interfaces, How and Why?

Authors:  Ezgi Karaca; Chantal Prévost; Sophie Sacquin-Mora
Journal:  Molecules       Date:  2022-03-11       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.